Sun Pharmaceutical Industries, Inc.

Quick facts

Marketed products

• Desoximetasone Spray 0.25% · Dermatology
  Desoximetasone is a topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.
• Lotrimin Ultra® · Dermatology / Infectious Disease
  Lotrimin Ultra contains butenafine, an allylamine antifungal that disrupts fungal cell membrane synthesis by inhibiting squalene epoxidase.
• Placebo topical cream
  A placebo topical cream contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.

Phase 3 pipeline

• DSXS · Diabetes
  DSXS is a small molecule that targets the SGLT2 receptor.
• DSXS topical · Dermatology
  DSXS is a topical formulation designed to deliver active pharmaceutical ingredients to skin lesions or dermatological conditions through enhanced penetration.
• Malathion gel 0.5% · Dermatology / Parasitology
  Malathion is an organophosphate insecticide that inhibits acetylcholinesterase, causing accumulation of acetylcholine and paralysis of parasites.
• Naftifine Hydrochloride Cream 2% · Dermatology / Infectious Disease
  Naftifine is a fungistatic agent that inhibits fungal sterol synthesis by blocking squalene epoxidase, disrupting the fungal cell membrane.
• Onexton™ Gel · Dermatology
  Onexton is a topical combination gel containing clindamycin and benzoyl peroxide that reduces acne by killing bacteria and decreasing sebum production.
• Ovide (malathion) lotion 0.05% · Dermatology
  Ovide (malathion) lotion works by killing lice and their eggs on the scalp.
• Permethrin 1% rinse · Dermatology
  Permethrin 1% rinse works by killing or repelling insects and other arthropods through its insecticidal properties.

Phase 2 pipeline

• ADPS topical product · Dermatology
  ADPS topical product is a small molecule that targets the skin to treat various conditions.
• Desoximetasone 0.05% once daily
• Desoximetasone 0.05% twice daily
• Desoximetasone 0.25% once daily
• DSXS topical product · Dermatology
  DSXS topical product is a corticosteroid that reduces inflammation and itching by suppressing the immune system.
• DSXS1411
• NVXT Solution
• NVXT topical
• Tretinoin cream 0.1%

Phase 1 pipeline

• Aldara - Imiquimod 5%
• Azelaic Acid 15% topical gel
• Bactroban® Cream
• BenzaClin® Topical Gel
• Butenafine cream 1% manufactured by Taro
• Butenafine Hydrochloride Cream, 1%
• CABTREO Topical Gel
• Clindamycin and Benzoyl Peroxide Gel 1%5%
• Clindamycin Phosphate RLD
• CLPG Topical Gel 1%
• DPSG 7.5%
• Duac® Topical Gel
• Imiquimod 5% manufactured by Taro
• Imiquimod Topical Cream 3.75%
• Ivermectin Lotion, 0.5%
• Malathion lotion 0.5%
• Metronidazole Topical Gel 1%
• Naftifine HCl Cream 1%
• Naftin® Gel 2%
• Oxiconazole Nitrate Cream 1%
• Oxymetazoline hydrochloride Cream, 1%
• Protopic - Tacrolimus 0.1%
• RETIN-A® Cream
• Ruxolitinib Topical Cream 1.5%
• TA103
• Tacrolimus 0.1% manufactured by Taro
• Topical TA-102 D
• Tretinoin Gel Microsphere, 0.04%
• Tretinoin Gel Microsphere, 0.1%
• Trifarotene Cream 0.005%

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Sun Pharmaceutical Industries, Inc. portfolio CI brief
• Sun Pharmaceutical Industries, Inc. pipeline updates RSS